The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $342.41

Today's change-2.03 -0.59%
Updated January 19 4:00 PM EST. Delayed by at least 15 minutes.
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $342.41

Today's change-2.03 -0.59%
Updated January 19 4:00 PM EST. Delayed by at least 15 minutes.

Biogen Inc down (U.S.)$2.03

Biogen Inc closed lower Friday, dropping (U.S.)$2.03 or 0.59% to (U.S.)$342.41. Over the last five days, shares have gained 1.92% and are currently 1.84% off of the 52-week high. Over the last year, this stock has underperformed the S&P 500, gaining 22.14% vs. the index's 24.15%.

Key company metrics

  • Open(U.S.) $347.57
  • Previous close(U.S.) $344.44
  • High(U.S.) $347.57
  • Low(U.S.) $341.82
  • Bid / Ask(U.S.) $280.00 / (U.S.) $349.90
  • YTD % change+7.48%
  • Volume1,232,214
  • Average volume (10-day)1,209,109
  • Average volume (1-month)1,122,744
  • Average volume (3-month)1,227,700
  • 52-week range(U.S.) $244.28 to (U.S.) $348.84
  • Beta0.73
  • Trailing P/E20.99×
  • P/E 1 year forward15.56×
  • Forward PEG2.18×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $16.31
Updated January 19 4:00 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue3,0783,0782,8112,872
Total other revenue--------
Total revenue3,0783,0782,8112,872
Gross profit2,7082,7122,4262,494
Total cost of revenue370366385379
Total operating expense1,4241,8781,7861,986
Selling / general / administrative434430499496
Research & development446796423534
Depreciation / amortization109118449104
Interest expense (income), net operating--------
Unusual expense (income)01200467
Other operating expenses, total302110-4
Operating income1,6541,2011,024886
Interest income (expense), net non-operating-62-64-63-65
Gain (loss) on sale of assets--------
Other--------
Income before tax1,6101,132987838
Income after tax1,226863748648
Income tax, total384270239190
Net income1,226863748649
Total adjustments to net income--------
Net income before extra. items1,226863748649
Minority interest0001
Equity in affiliates0000
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,226863748649
Inc. avail. to common incl. extra. items1,226863748649
Diluted net income1,226863748649
Dilution adjustment--------
Diluted weighted average shares212212216217
Diluted EPS excluding extraordinary itemsvalue per share5.794.073.462.99
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share5.794.633.464.65